AZINTUXIZUMAB VEDOTIN

UNII:	6XQ9TM3U2G
Formula:
Preferred Substance Name:	AZINTUXIZUMAB VEDOTIN
GSRS Full Record:	6XQ9TM3U2G i

1826819-58-2
ABBV-838
AZINTUXIZUMAB VEDOTIN [INN]
AZINTUXIZUMAB VEDOTIN [WHO-DD]
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD319 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL PR-1471272 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL PR-1471272 LIGHT CHAIN, DIMER, BIS(THIOETHER) WITH N-(((4-((N-(6-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)-1-OXOHEXYL)-L-VALYL-N5-(AMINOCARBONYL)-L-ORNITHYL)AMINO)PHENYL)METHOXY)CARBONYL)-N-METHYL-L-VALYL-N-((1S,2R)-4-((2S)-2-((1R,2R)-3-(((1R,2S)-2-HYDROXY-1-METHYL-2-PHENYLETHYL)AMINO)-1-METHOXY-2-METHYL-3-OXOPROPYL)-1-PYRROLIDINYL)-2-METHOXY-1-((1S)-1-METHYLPROPYL)-4-OXOBUTYL)-N-METHYL-L-VALINAMIDE

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

AZINTUXIZUMAB VEDOTIN

Synonyms and Mappings

Resources